MRI for May-Thurner Syndrome
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial explores blood flow through the pelvic veins using MRI scans. It aims to understand patterns in healthy individuals, those with May-Thurner syndrome (a condition where the left iliac vein is compressed), and people with a stent in the iliac vein. The research seeks to identify normal and abnormal blood flow characteristics to improve treatments. Potential participants include those with symptoms of May-Thurner syndrome or a history of having a stent placed in the iliac vein. Healthy volunteers without any history of pelvic vein issues are also needed. As an unphased trial, this study allows participants to contribute to foundational research that could lead to better diagnostic and treatment options for pelvic vein conditions.
What prior data suggests that this MRI technique is safe for assessing iliac vein flow?
Research shows that the type of MRI used in this study, known as 2D and 4D flow MRI, is generally easy for participants to handle. This imaging method is safe and does not use contrast agents, reducing the risk of allergic reactions. For individuals with May-Thurner syndrome, this MRI provides a clear view of blood flow without any known side effects.
For those with an iliac stent, similar MRI methods have been used successfully. Studies indicate that these scans do not harm the stent or affect blood flow. Reports of negative side effects from these MRI scans are uncommon.
Overall, evidence suggests that 2D and 4D flow MRI safely examines blood flow in the pelvis, offering reassurance about the procedure's safety.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores the use of 2D and 4D flow MRI without contrast to better understand May-Thurner Syndrome and related conditions. Unlike traditional imaging methods that often require contrast agents, which can pose risks for some patients, this technique provides a non-invasive way to evaluate blood flow dynamics. This approach could lead to safer, more comfortable diagnostics for patients with or without prior treatments like stent placements. By providing detailed insights into blood flow, it could transform how we diagnose and monitor pelvic venous diseases, potentially improving patient outcomes with less risk.
What evidence suggests that this MRI technique is effective for assessing May-Thurner syndrome?
Research has shown that 2D and 4D flow MRI can help examine blood flow in the pelvic veins, which is important for conditions like May-Thurner syndrome. In this trial, participants with left iliac vein compression syndrome will undergo these imaging methods to clearly show how blood moves through the veins, aiding in the understanding and diagnosis of vein compression. Another group of participants, those with stents in their iliac veins, will also undergo 4D flow MRI to assess stent performance by showing blood flow unaffected by metal. Additionally, healthy volunteers with no imaging evidence of iliac venous disease will be studied to provide baseline comparisons. These techniques have the potential to improve the diagnosis and management of long-term vein problems. Overall, 2D and 4D flow MRI offer valuable insights that could lead to better treatment outcomes.12678
Who Is on the Research Team?
Ningcheng Li, MD
Principal Investigator
UMass Chan Medical School
Are You a Good Fit for This Trial?
This trial is for individuals with or without May-Thurner Syndrome, which is a condition where the left iliac vein is compressed. It's also for those who have had stents placed in their iliac veins. Participants should be suitable candidates for MRI scans.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Baseline flow characteristics of the iliac veins are established using 2D and 4D flow MRI
Follow-up
Participants are monitored for changes in flow characteristics and quality-of-life measures
What Are the Treatments Tested in This Trial?
Find a Clinic Near You
Who Is Running the Clinical Trial?
Ningcheng Peter Li
Lead Sponsor